Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Nat Immunol

Retrieve available abstracts of 23 articles:
HTML format

Single Articles

    October 2022
  1. FOURATI S, Tomalin LE, Mule MP, Chawla DG, et al
    Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination.
    Nat Immunol. 2022 Oct 31. pii: 10.1038/s41590-022-01329.
    PubMed     Abstract available

  2. HAGAN T, Gerritsen B, Tomalin LE, Fourati S, et al
    Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses.
    Nat Immunol. 2022 Oct 31. pii: 10.1038/s41590-022-01328.
    PubMed     Abstract available

  3. QUAST I, Tarlinton D
    Time is of the essence for vaccine success.
    Nat Immunol. 2022 Oct 21. pii: 10.1038/s41590-022-01347.

    September 2022
  4. BRASU N, Elia I, Russo V, Montacchiesi G, et al
    Memory CD8(+) T cell diversity and B cell responses correlate with protection against SARS-CoV-2 following mRNA vaccination.
    Nat Immunol. 2022 Sep 22. pii: 10.1038/s41590-022-01313.
    PubMed     Abstract available

    July 2022
  5. HERATI RS, Knorr DA, Vella LA, Silva LV, et al
    PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine.
    Nat Immunol. 2022 Jul 28. pii: 10.1038/s41590-022-01274.
    PubMed     Abstract available

    PD-1 blockade unblocks immune responses to vaccination.
    Nat Immunol. 2022 Jul 28. pii: 10.1038/s41590-022-01254.

  7. YU D, Walker LSK, Liu Z, Linterman MA, et al
    Targeting TFH cells in human diseases and vaccination: rationale and practice.
    Nat Immunol. 2022 Jul 11. pii: 10.1038/s41590-022-01253.
    PubMed     Abstract available

  8. QI H, Liu B, Wang X, Zhang L, et al
    The humoral response and antibodies against SARS-CoV-2 infection.
    Nat Immunol. 2022;23:1008-1020.
    PubMed     Abstract available

    May 2022
  9. LUSTIG Y, Gonen T, Meltzer L, Gilboa M, et al
    Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose.
    Nat Immunol. 2022 May 9. pii: 10.1038/s41590-022-01212.
    PubMed     Abstract available

    March 2022

  10. IL-1-mediated inflammation induced by different RNA vaccines is context-specific.
    Nat Immunol. 2022 Mar 30. pii: 10.1038/s41590-022-01177.

  11. KOBIYAMA K, Ishii KJ
    Making innate sense of mRNA vaccine adjuvanticity.
    Nat Immunol. 2022 Mar 30. pii: 10.1038/s41590-022-01168.

  12. TAHTINEN S, Tong AJ, Himmels P, Oh J, et al
    IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines.
    Nat Immunol. 2022 Mar 24. pii: 10.1038/s41590-022-01160.
    PubMed     Abstract available

  13. LI C, Lee A, Grigoryan L, Arunachalam PS, et al
    Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine.
    Nat Immunol. 2022 Mar 14. pii: 10.1038/s41590-022-01163.
    PubMed     Abstract available

    A potential silver lining of delaying the second dose.
    Nat Immunol. 2022;23:349-351.

    February 2022
  15. TOMALKA JA, Suthar MS, Deeks SG, Sekaly RP, et al
    Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses.
    Nat Immunol. 2022 Feb 24. pii: 10.1038/s41590-022-01130.
    PubMed     Abstract available

  16. HALL VG, Ferreira VH, Wood H, Ierullo M, et al
    Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses.
    Nat Immunol. 2022 Feb 3. pii: 10.1038/s41590-021-01126.
    PubMed     Abstract available

    January 2022
  17. EGWANG TG, Owalla TJ, Kemigisha M
    COVID-19 vaccine trials must include helminth-infected cohorts.
    Nat Immunol. 2022 Jan 24. pii: 10.1038/s41590-021-01116.

  18. DOWELL AC, Butler MS, Jinks E, Tut G, et al
    Children develop robust and sustained cross-reactive spike-specific immune responses to SARS-CoV-2 infection.
    Nat Immunol. 2022;23:40-49.
    PubMed     Abstract available

    December 2021
    Vaccine thrombosis.
    Nat Immunol. 2021 Dec 22. pii: 10.1038/s41590-021-01111.

    November 2021
  20. BREWER RC, Ramadoss NS, Lahey LJ, Jahanbani S, et al
    BNT162b2 vaccine induces divergent B cell responses to SARS-CoV-2 S1 and S2.
    Nat Immunol. 2021 Nov 30. pii: 10.1038/s41590-021-01088.
    PubMed     Abstract available

  21. IRVINE EB, O'Neil A, Darrah PA, Shin S, et al
    Robust IgM responses following intravenous vaccination with Bacille Calmette-Guerin associate with prevention of Mycobacterium tuberculosis infection in macaques.
    Nat Immunol. 2021 Nov 22. pii: 10.1038/s41590-021-01066.
    PubMed     Abstract available

  22. NIAID workshop on secondary vaccine effects.
    Nat Immunol. 2021;22:1363-1366.

    October 2021
  23. CORBETT KS, Werner AP, Connell SO, Gagne M, et al
    mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates.
    Nat Immunol. 2021;22:1306-1315.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.